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Feasibility of continuous fever
monitoring using wearable devices
Benjamin L. Smarr1*, Kirstin Aschbacher2,3, Sarah M. Fisher4, Anoushka Chowdhary4,
Stephan Dilchert5, Karena Puldon6, Adam Rao6, Frederick M. Hecht4,8 & Ashley E. Mason4,7,8
Elevated core temperature constitutes an important biomarker for COVID-19 infection; however,
no standards currently exist to monitor fever using wearable peripheral temperature sensors.
Evidence that sensors could be used to develop fever monitoring capabilities would enable largescale health-monitoring research and provide high-temporal resolution data on fever responses
across heterogeneous populations. We launched the TemPredict study in March of 2020 to capture
continuous physiological data, including peripheral temperature, from a commercially available
wearable device during the novel coronavirus pandemic. We coupled these data with symptom reports
and COVID-19 diagnosis data. Here we report findings from the first 50 subjects who reported COVID19 infections. These cases provide the first evidence that illness-associated elevations in peripheral
temperature are observable using wearable devices and correlate with self-reported fever. Our
analyses support the hypothesis that wearable sensors can detect illnesses in the absence of symptom
recognition. Finally, these data support the hypothesis that prediction of illness onset is possible
using continuously generated physiological data collected by wearable sensors. Our findings should
encourage further research into the role of wearable sensors in public health efforts aimed at illness
detection, and underscore the importance of integrating temperature sensors into commercially
available wearables.
Fever is the first symptom listed in the Center for Disease Control and Prevention’s (CDC’s) “Quarantine and
Isolation” informational site as of this w
 riting1. There, fever is defined as “a measured temperature of 100.4 °F
(38 °C) or greater, or feels warm to the touch” (our emphasis). Herein we assess data compared to subjective illness reports, and so use a more colloquial definition: Fever refers to an atypical elevation in body temperature
generally (but not always) associated with an immunologic response to viral or bacterial i nfection2. Individual
and government efforts to track the spread of SARS-CoV2 (in which infection is characterized by f ever3) have
employed classical thermometry at largely random timepoints, for example when entering a workplace or boarding a b
 us4,5. However, single-point measures have limited sensitivity to detect disease, particularly in the earliest stages of onset6; this lack of utility has dampened the perceived value of temperature assessment in disease
prevention and containment. Further, some researchers have used the difficulties with single-point measures
to argue that data from wearable devices cannot be used to detect f ever7. This is not surprising, as sensitivity
to detect small, but meaningful, changes in body temperature may be limited without contextual information,
such as baseline variability in circadian body temperature8, phase in menstrual cycle8–10, and other temperaturemodulating biological r hythms8 at the time of measurement. Without these contexts for measured individuals,
inferring fever from a single-thermometry assessment is reliable only when the fever is well outside the range of
these normal variations. It is likely that our current reliance on single-point temperature assessment has led to
missed case identification, as indeed, the COVID-19 pandemic has not abated despite growing use of temperature
checks, for example, upon entry to restaurants, stores, and air travel. Fundamentally, the question is about feasibility: Can continuous temperature observations allow us to extract information from temperature as a signal,
and thereby overcome the barriers that have stymied efforts using single-point measurements?
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◂Figure 1.  Wearable distal temperature sensors are suitable for developing digital biomarkers for fever with

and without paired symptom reports. 50 individuals (a) display a wide range of temperatures (inter-individual
means ± standard deviation) both during baseline (dark blue) and symptom report window (pail lines); there is
a small but significant difference between the two sets of means. Having been normalized (norm) by individual
range (see “Methods”), the mean 65-day temperature profile for individuals reporting fever (purple) and those
not reporting fever (orange) reveal an apparent rise in maximum finger temperature (T) in fever-reporting cases
near the beginning of the symptom window (black arrow; symptom window: grey box, mean duration for the
whole population). Norm daily maximum (c) and minimum (d) T highlights changes in both that correspond to
fever onset report. Such cases informed the construction of digital biomarkers in the form of thresholds for daily
max and min that identify fever-like days. An example T record (e) with fever-like days identified by exceeding
these thresholds before onset of symptom report (e; black dots represent daily min and max above thresholds)
has similar changes in heart rate (HR), HR variability (HRV), and respiration rate (RR), to the reported
fever event (f by variable, and g,h with overlay, respectively). (f–h) All lines are smoothed by 360 min radius,
displaying the same smoothing used to generate median minimum and maximum values for each day. Faded
blue line in (g,h) is the raw T (1 point/min).
Wearable sensor devices (wearables) equipped with temperature sensors could provide useful contextual
information while assessing temperature, which we hypothesize would make temperature data more useful in
fever detection. To our knowledge, no published data have shown that wearables might be a useful tool in fever
identification (but s ee11 for comparison). Wearables that are consumer goods make a potential ready-to-use
distributed monitoring system for changes to health within individuals and across whole populations. Evidence
that wearables can detect fever should therefore be of interest to public health efforts, particularly in the context
of pandemics.
We launched TemPredict in March of 2020 to assess whether we could identify the onset of COVID-19 symptoms using continuously collected, wearables-derived dermal temperature data from the Oura ring sensor device.
No prior studies have demonstrated the feasibility of using such data to identify fevers. Although TemPredict
is still ongoing, here we present early results from the first 50 subjects with enough data to meet analysis inclusion criteria. In these analyses, we demonstrate that fever detection and prediction via wearables is a promising
avenue for research focused on improving fever tracking in the COVID-19 pandemic and future pandemics.

Results

Participants. Demographic and background information was available for all 50 participants. Most participants resided in the US (33; 66%), with an additional 6 participants in the UK, 3 in Finland, and 1 each in Austria, Canada, Germany, Honduras, Italy, The Netherlands, Norway, and Sweden. Of the 33 participants residing
in the US, 11 lived in the state of California, 4 in New York, 3 in Florida, 2 each in New Jersey, North Carolina,
and Washington, and 1 each in Massachusetts, Georgia, Minnesota, Illinois, Texas, Utah, and Oregon. Six participants (12%) indicated they worked at least 50% of their time in places where they are potentially in contact
with patients seeking treatment for symptoms that characterize COVID-19. Of those 6 participants, 2 were
attending physicians, 1 a nurse/nurse assistant, 2 were respiratory therapists, and 1 occupied another medical
role. Most participants (66%) indicated their biological sex as male. Average age was 43.7 years (SD = 11.0, range
24–76, median = 40.5). Average household size was 3 (SD = 1.3, range 1–6, median = 3). Most participants held
a 4-year college degree or higher (36% Bachelor’s, 26% Master’s, 12% professional [MD/JD etc.], 12% doctorate). Of the 48 participants who indicated their race or ethnicity, the majority (39; 81%) identified as Caucasian/
White, 8 as Hispanic/Latino, 1 as Middle Eastern, 1 as Asian, 1 as South Asian, and 3 as “other” (then indicating
they were of “European”, “Scandinavian”, or “Jewish” ethnicity). Of these 50, 35 had complete 65 day data windows (see “Methods”); 3 had ≤ 3 weeks prior; 2 had < 4 weeks prior; 2 had < 5 weeks prior; 1 had 6 weeks prior;
1 had 43 days prior.
Is a single temperature value appropriate to identify fever using finger skin temperature? We
found substantial inter-individual variance in both mean and range (Fig. 1a; population mean ± standard deviation: 31.2 ± 1.7 °C). We observed a significant increase in T during the symptom window compared to baseline
(Fig. 1a, dark and light lines, respectively; Wilcoxon rank-sum test of means by baseline vs symptom window,
mean difference of + 0.63 ± 1 °C; p = 0.024). These findings support our hypothesis that wearables could be used
to identify fever, while underscoring that the intra-individual variability is substantial enough that using a single
temperature value (i.e. 38 °C) across all individuals would not be appropriate.
Do wearable temperature time series show changes associated with fever self‑reports? Given
our positive finding of mean increase T following symptom onset, we next assessed the data for signs that their
continuous nature adds information related to reported fevers not easily assessed by single time-point measurements. Our first observation was that most intra-individual temperature variance is attributable to daily
rhythms, with twice-daily large transitions between lower temperatures during the daytime (daily minimums),
and higher temperatures across the night (daily maximums). Second, we noticed that participants who reported
a fever (n = 38; 76%) also appeared to exhibit elevated maximum temperature concordant with symptom onset
(Fig. 1b, dark line: mean temperatures across all 65 days for subjects reporting fever; orange line: mean temperatures across all 65 days for individuals not reporting a fever; grey box: average duration symptom window).
Individuals not reporting fever (n = 12, 24%) did not show this rise in the sample average. Given these two
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observations, we generated representative “daily minimum” and “daily maximum” values across all days for
all subjects, and normalized these further to allow uniform comparison (see “Methods”). Comparison within
these minimum and maximum values provided clearer signals of temperature change associated with fever selfreports (Fig. 1c,d). The average daily maximum rose sharply and significantly as symptom onset approached
(baseline vs 1st week of symptom window, rank sum test, with no fever-like days detected: p = 0.4; with fever-like
days detected, p = 8 × 10–6), and the daily minimum showed a longer, more steady significant increase to a peak
near reported symptom onset (baseline vs 1st week of symptom window, rank sum test, with no fever-like days
detected: p = 0.4; with fever-like days detected, p = 2 × 10–5).

Can observed patterns be used to develop digital biomarkers of probable fever? Given the
different behavior of nighttime and daytime temperature, we chose to create one biomarker for each extreme
(see “Methods”). Because the point of this exploration was to test the feasibility of using wearable data for fever
prediction and detection, and not to provide a global solution to fever monitoring (which would be inappropriate with such a small cohort), we did not develop biomarkers by machine learning (ML) or similar extraction.
Rather, we assigned a threshold applied to the normalized daily minimum and maximum values to catch excursions associated with fever reports. We scored days exceeding either threshold (day or nighttime) as “fever-like”
days. With these thresholds, 3/38 of those who reported fevers did not have fever-like days within their reported
symptom window, whereas 7/12 who did not report fever nevertheless had fever-like days within their reported
symptom window. To investigate when disagreements between self-report and digital biomarker-based detection
might be due to imprecision of the digital biomarkers, and when they might instead be due to failure to notice
or report fevers, we next compared to changes from other physiological variables at these detected episodes to
assess the presence of coordinated disruptions that might reflect illness or related physiological disruption.
Can appropriateness of digital biomarkers be assessed to guide future refinement? When we

re-sorted individuals into groups of those with (n = 42) and those without (n = 8) detected temperature-derived
fever-like days during the symptom window, other physiological changes became more pronounced. Specifically,
we observed larger and significant changes between the baseline and symptom windows for those with detected
fever-like days, as compared to those with reported fever. Sorting individuals into groups using symptom
report led to a non-significant difference between the baseline and the first week of reported symptoms (chosen
because that is where the major temperature change was observed, on average; Supp 1) for HR and HRV (mean
difference ± S.E.: HR: 0.49 ± 0.25 to 1.48 ± 0.28; HRV: − 0.15 ± 0.25 to − 0.42 ± 0.15; Tukey–Kramer post-hoc
analysis following Kruskal–Wallis non-parametric comparison, bonferroni corrected; p = 0.13, p = 0.33, respectively). Unlike in HR and HRV, we did observe a significant difference in RR from baseline to during symptoms
(− 0.12 ± 0.1 to 0.3 ± 0.06; p = 0.002), consistent with CDC reports that fever and respiratory distress are the two
most common COVID-19 symptoms. By contrast, re-sorting individuals by digital biomarker resulted in significant differences between baseline and baseline and reported symptom windows in all three variables: HR, HRV,
and RR (HR: 0.13 ± 0.28 to 1.45 ± 0.25, p = 0.02; HRV: 0.26 ± 0.13 to − 0.48 ± 0.14, p = 0.03; RR: − 0.06 ± 0.08 to
0.24 ± 0.07, p = 0.01). To summarize, baseline and symptom-onset HR and HRV were not significantly different
in the population sorted by fever self-report, but were significantly different once sorted by temperature-derived
digital biomarker.

Can digital biomarkers be used to study the potential of illness detection before symptom
report? We applied our digital biomarkers across the 45 days prior to symptom onset. 38/50 subjects had

fever-like days before reporting symptoms (e.g. Fig. 1e). To assess whether such events had other evidence of illness, as opposed to false positives, we examined other physiological outputs from the same time windows (heart
rate, heart rate variability, and respiration rate). We visually inspected the changes across fever-like days before
and during the reported symptom window, and found that many showed similar patterns to the change associated with fever detection just described (Fig. 1f,g): coordinated change across multiple physiological variables
(T, HR, HRV, RR).

If feasibility fever detection is so solid, where’s my flying car? Our visual examination of fever-like

days also revealed substantial heterogeneity, both inside and outside the reported symptom windows. Despite
a clear average of increased T min and max associated with reported fevers (Fig. 1), the exact trajectories of
temperature deviation showed substantial variance across individuals and episodes (e.g. Supp 2A,B). Consistent
with this observation, correlations across variables yielded low overall r-values (Supp 2C); the highest correlations are between cardiac variables (Supp 2C, circled), which are expected to be more related than other pairings
due to the fact that increased sympathetic nervous system tone tends to both elevate HR and decrease H
 RV12.
All individuals show a similar loose cluster of baseline ranges in the four variables assessed: T, HR, HRV, RR
(Fig. 2, white points). Relative to individuals for whom fever-like days were not detected during their reported
symptom window (Fig. 2a), individuals with detected fever-like days in their reported symptom window tended
to have elevated temperature in a fever-associated excursion from this baseline cluster, in which HR increased
and HRV decreased (Fig. 2b). Elevated temperature also occurred within baseline ranges of HR and HRV (Fig. 2,
red veins within baseline-cluster-defined space). RR also tended to be higher in this fever-associated excursion
space, though again, the linear correlation values were not high.

Is there evidence that continuous data could feasibly be used to develop fever prediction capabilities? Predicting onset of fever-report by identifying preceding T excursions is different than detecting the

T excursions themselves. Destabilization of circadian rhythms is a risk factor for illness, and may be an early sign

Scientific Reports |
Vol:.(1234567890)

(2020) 10:21640 |

https://doi.org/10.1038/s41598-020-78355-6

4

www.nature.com/scientificreports/

Figure 2.  Elevated temperature is clearly detectable, but only loosely correlated to changes in HR, HRV, and
RR. All time points for all individuals with original (not interpolated) measurements from temperature (T),
heart rate (HR), HR variability (HRV), and respiration rate (RR) sorted into those not showing fever-like days
during their reported symptom window (a) and those showing fever-like days during their reported symptom
windows (b). Baseline points: white. Symptom windows: color (bar in lower left, b, proportional to T, max set
to threshold of digital biomarker for nighttime fever detection). Dark background points: symptom window
from opposite group for comparison. Dot size proportional to RR. Insets: symptom window (dark) and baseline
(white) points for that panel. NB: despite being normalized by the mean of baseline day min and max values as
described for temperature (see “Methods”), HR and HRV show wide ranges, reflecting large day-to-day variance
within individuals. Larger and redder spots are more apparent in the “fever-associated excursion” but not
restricted to this region, reflecting the lack of strong correlation across variables. Both panels use identical axes
as well as scales for color and size.
of physiological d
 isruption13–15. The continuous nature of the temperature observations allowed us to use frequency decomposition to identify changes in approximately circadian power (ACP) that suggest the capability
of these data to generate features useful for fever prediction efforts. Using a continuous wavelet decomposition
(Fig. 3a), we extracted ACP bands (see “Methods”). Consistent with our hypothesis, we found unique ACP peaks
(Fig. 3b) within one week before the onset of 226 of the 244 day time fever-like episodes that were detected in the
data set (93%, Fig. 3d). Eighteen daytime fever-like days did not have a unique ACP peak preceding them (7%).
We found a significant positive correlation between the ACP peak height and number of days until the fever-like
day (r = 0.36, p = 1 × 10–7, Fig. 3c). The mean distance was 3 days prior to onset of daytime fever-like event, and
ranged from 1–7 days, which was our assigned boundary.

Discussion

These findings provide proof-of-concept for the feasibility of wearables-based temperature sensors to support
productive research into fever-associated illness, within individuals and across distributed populations. First, our
findings refute previous concerns that distal body temperature is too different from tympanic temperature to be
useful in detecting f evers7. This previous claim was based on single time-point measures, and so the difference
highlights the importance of longitudinal, high temporal-resolution data gathered within individuals. We used
distal temperature data from wearables to detect changes in daily rhythms, and disturbances of thermoregulation
that correspond with self-reported fevers. These data were suitable for the construction of digital biomarkers,
which, when applied to the total population, had two encouraging findings. First, physiological differences from
pre- to in-symptom window were stronger after re-sorting from “by reported fever” to “by digital biomarkers”
(defined in “Methods”). This sign of enhanced sorting is consistent with the limited accuracy of self-reported
symptoms in detecting physiological c hanges16–18. It supports the hypothesis that some fever-like events may go
unreported or unnoticed without being truly asymptomatic; wearables therefore may contribute to identifying
rates of asymptomatic as opposed to unreported illness, of special importance in the COVID-19 pandemic. An
important limitation here is the lack of serology or other ground-truthing measures to confirm individuals’
conditions. Rather than pushing the utility of these specific digital biomarkers in detecting conditions such as
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Figure 3.  Use of signal-processing allows identification of more complex digital biomarkers in continuous data.
Wavelet frequency decomposition (a) provides a frequency-by-time surface usable for feature extraction from
continuous data. We found that 226/244 daytime fever-like events as detected by digital biomarker (d, aligned
by onset) are preceded by a relative peak in the power of the ~ 22–26 h frequency band (b, all instances aligned
by peak; mean: lighter fat line; median: darker fat line); example peak and alignment to fever-like day 2 days
later (a, above to below; dots are temperature minimums for days with daytime fever threshold exceeded). The
relative height of the wavelet peak correlates loosely but significantly (r = 0.36, p = 1 × 10–7) with time to fever
onset (c). Hollow dots: points from individuals without detected fever-like days during reported symptom
window; filled dots: points from individuals with detected fever-like days during their reported symptom
window. Transparency highlights where points overlap and cluster.
COVID-19 disease, this manuscript is meant to encourage future research and applications; ideally development
of such biomarkers would be coupled to symptom report and further supported by serology or other physiological confirmations of specific conditions.
Second, the majority of participants exhibited temperature anomalies prior to symptom reports (38/50),
which could be flagged for investigation by comparison across other physiological variables (increased HR and
RR, decreased HRV). Specifically, upon viral or bacterial infection, innate immune cells secrete proinflammatory
cytokines, which alter central nervous system firing rates of warm-sensing neurons in the hypothalamus2,19,20. This
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process results in an increase in the temperature steady state, which is generally adaptive in fighting i nfection2,19.
Moreover, it is accompanied by peripheral blood vessel vasoconstriction or vasodilation as a negative feedback
mechanism, which conserves or releases heat (respectively), in order to help regulate temperature19,21. Hence,
a multi-metric digital biomarker combining temperature and PPG-derived information would appear likely to
provide superior illness prediction than single-signal models. To the extent these profiles systematically differ by
condition, they make time series temperature, heart rate, heart rate variability, and respiratory rate data useful for
early-stage indicators in illness detection and determination. Contextual information, obtained via this multisignal profiling, may more effectively capture the dynamic physiological mechanisms that respond to infection
than temperature alone. Specific studies to identify such high-dimensional biomarkers in specific pathologies
(e.g. COVID-19 and other viral infections, physical exhaustion, etc.) should be supported. We believe these
findings additionally show feasibility in support of investigations into the difference between “asymptomatic”
and “cryptic” unnoticed, but nevertheless symptomatic, illnesses.
To date, most wearables do not use temperature sensors. This should be re-examined, as temperature contains
rich physiological i nformation8,22–24; distal temperature is not well mapped, but has been shown to include cues
to context like daily and ultradian rhythms23. Moreover, the relationships across individual variables through
time are not simple linear functions, and so inference of one from another (as in, projecting fevers from HR)
is not a trivial problem. Additionally, the continuous nature of these data allow for modeling of these complex
relationships, and are amenable to signal process approaches. These approaches allow for richer feature detection,
expanding the kinds of patterns that may be visible and put to work for illness-related research and applications.
It is for this last reason that, upon completion, TemPredict is hosting all data at UCSD as a curated research object
to enable collaborative discovery efforts.
Despite our positive feasibility findings, we also found that major complexities lie between this work and the
invention of COVID-19 detection algorithms that would be robust across individuals. The key challenges can be
summarized as follows: people are different, and so are physiological systems. Taking examples displayed within
this manuscript, the amplitude of daily rhythm, stability across days, correlation across variables, and stability of
those correlations all change within and across individuals, both in and out of reported illness. Data from large
populations willing to share information about their demographics, habits, and health will be needed to appropriately model these various flavors of variance if the COVID-19 component of those patterns is to be identifiable
across such different baselines. Given the real costs associated with biases in large data e ndeavors25–29 where
health is concerned, the most robust outcomes are likely to require these variance maps if they are to be useful
across heterogeneous populations. Additionally, while the quality of the data is determined by the design of the
hardware in large part (including ease of user compliance, comfort, etc.), here more than half our first responses
could not be used due to user choices. The majority were failure to generate data (not wearing the wearable, or
offering observations about illnesses before the user had a wearable) or failure to communicate critical details
(wrong contact / account information so that looking up data was impossible). The resulting initial 50 cases were
extremely useful, and we anticipate many more findings coming from the now ~ 1000 times larger TemPredict
cohort and other ongoing large-scale studies. Nevertheless, our findings bolster the need for social research into
fair wearable access and personal data trust (from the user perspective, as opposed to technical security issues),
as well as efforts at data literacy education so that people (users, clinicians, policy makers, etc.) can understand
the potential and the pitfalls within the generation and use of large, user-driven health data sets.

Conclusions and implications for future work

This work shows the feasibility of gathering fever-related information from distributed populations using wearables. Our findings also suggest that the success of attempts to identify COVID-19 with specificity from wearables
will require multiple physiological variables for corroboration. By coupling the wearable data to an online questionnaire, we further demonstrate the relative efficiency of gathering both physiology data and health-relevant
“labels” or outcomes for research. Many caveats follow these feasibility endorsements. This work is only the
proof of concept to support a great deal of future work. We see great potential for public health advancements
from distributed physiological information systems, and we hope the caveats encourage deeper engagement and
creative problem solving. The combination of many potential conditions across many kinds of people suggests
large and sustained efforts and community engagement will be critical for this and related efforts to succeed. Best
practices need to be developed to grow the potential of distributed, participatory, wearable-enabled research into
a reality that is stable, safe, and productive for all parties.

Methods

Participants. Overall Inclusion criteria for TemPredict include: (1) being 18 years of age or older, (2) possessing an Oura smartring that pairs with the Oura App on a user’s smartphone, and (3) informed consent given
for study participation. Participants in these analyses possessed Oura smartrings prior to TemPredict. We did
not compensate participants for their participation. All participants completed an online consent process delivered via a secure Qualtrics survey platform under a UCSF license, which allowed respondents to download PDF
consent forms and indicate consent by responding to questions. Participants completed an intake survey that
collected demographic information and information on any COVID-19 diagnoses received prior to enrollment.
This survey included instructions for how participants could provide TemPredict researchers with access to their
Oura ring wearable data. Once enrolled, participants accessed a daily symptom survey through the Oura App
on their smartphone. This daily survey collected information on COVID-19 symptoms and (if applicable) if and
when the participants received any COVID-19 diagnoses or completed any relevant testing. Participants for this
analysis were selected from 110 initial individuals who enrolled in TemPredict and who reported that they had
experienced COVID-19 symptoms prior to enrolling in the study (Fig. 4); these participants then filled out a
Scientific Reports |
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Figure 4.  CONSORT (consolidated standards of reporting trials) format flow chart for exclusion of cases from
analyses. Although neither this effort nor TemPredict are clinical trials, we show exclusion of participants from
the larger dataset for ease of interpretation.

one-time questionnaire about their COVID-19 symptoms (see “Self-report measures” below). The University of
California San Francisco (UCSF) Institutional Review Board (IRB) approved all study procedures, and all work
was carried out in accordance with these approvals, and all relevant regulations.

Physiological measures. We collected all physiological measures using the Oura ring, a commercially

available wearable sensor device (Oura Health, Oulu, Finland). The Oura ring connects to the Oura App (available from the Google Play Store or the Apple App Store) via Bluetooth. Users wear the ring on any finger and can
wear the ring continuously in wet and dry environments while doing activity that a human hand can tolerate.
The Oura ring assesses temperature using a negative temperature coefficient (NTC) thermistor (non-calibrated,
resolution of 0.07 °C) on the internal surface of the ring. The sensor is programmed to register skin temperature
readings from the palm side of the finger base every minute. The Oura ring assesses heart rate, heart rate variability, and respiration rate by extracting features from a photoplethysmogram (PPG) signal generated at 250
Hz. Specifically, respiration rate (RR) observations are stored at 30 s resolution; heart rate (HR) is provided as
the mean derived per 5 min of inter-beat interval (IBI); heart rate variability (HRV) is provided in the form of
RMSSD derived per 5 min of IBI; all of these metrics are generated on device, and the raw PPG is not continuously recorded or stored for analysis.

Self‑report measures. At intake, participants report on demographic factors including age, race/ethnicity,

educational background, and country/state of residence. Participants in these analyses reported on the date that
they first felt ill (“what date did you first notice symptoms?”), the date they believe they had recovered (“what
date would you say you recovered (defined as major symptoms resolved and feeling almost like your usual self)?”),
and symptoms they experienced (“When you suspected (or confirmed) that you had COVID-19, which of these
symptoms did you experience?”). For these analyses, we derived “symptom window” using these dates, and the
only symptom isolated in these analyses was “fever”.
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Data preparation. We prepared and analyzed data using Matlab 2019b. We generated visualizations in
Matlab and formatted and arranged them in Adobe Photoshop. Of the 110 first participants to respond to our
request for information about pre-TemPredict episodes of possible COVID-19 cases, 20 had such large windows
of missing Oura data that we deemed impossible any comparison of baseline data to sickness onset; 19 could not
be located in the Oura database (presumably due to typos in the information they reported to us); 16 did not
register Oura data prior to / during their reported episode, or began so close before that they could not generate
a prior baseline (threshold set to 14 days prior to first day of symptom report); 4 occurred before 2020, and so
were deemed unlikely to be COVID-19; and 1 was a second symptom episode from the same user, and we opted
to keep out pseudoreplication from our comparisons. These exclusions brought us to our first 50 usable episodes.
We aligned data from episodes of reported COVID-19 cases by time to the day of symptom report onset. Data
include heart rate (HR), heart rate variability (HRV), temperature (T), and respiratory rate (RR). We limited all
variables to a window starting 45 days prior to the first day of symptom report, and then 20 days subsequent,
counting inclusively of the first day with reported symptoms (65 days total, with all subjects aligned by the
day of symptom report onset). Across this dataset, all data were interpolated to 1 min resolution using a linear
interpolation. We indexed “baseline” as all data in days 1–40 pre-symptom report onset. We indexed “symptom
window” as each individual’s window of reported symptoms. For plots representing populations, the mean
symptom window duration is used in plotting (mean 9.3 days), but the analyses are carried out within-individual
using that individual’s symptom window.
To examine the overlap of ranges across individuals, we calculated T mean and standard deviation for each
individual over either their baseline window or their symptom window + 1 day prior to symptom onset. To
understand how changes in temperature correlated to symptom window, data were transformed into z-scores,
then representative daily minimum and maximum were generated by taking the median of the lowest and highest
360 min per 24 h window across the 65 days. In this way, minimum and maximum values were less dependent on
outlier events or acute extremes. The whole of the dataset was then normalized so that the mean of the baseline
daily min and max for all four physiological variables for each individual ranged from − 1 to 1. Fever threshold
was determined to be daily max > 1.2 or daily min > − 0.2. NB: no attempt was made to optimize these thresholds
beyond 1 significant digit, as the goal was to test feasibility of using such data to generate digital biomarkers,
and to avoid over-stating claims about precision from this initial cohort, which might encourage a reader to see
these values as solutions, rather than proofs of concept.
After dividing users into two groups based on the presence or absence of self-reported fever (n = 38, n = 12,
respectively), we used our digital biomarkers (temperature min and max thresholds) to re-sort subjects by presence or absence of detected fever-like day within their reported symptom window (n = 42, n = 8, respectively).
We then calculated group mean change between negative and positive fever groups in both sortings as difference
between baseline mean and the mean of the first week of symptom report for all variables. Difference between
groups was calculated using a nonparametric Kruskal Wallace test, with Tukey–Kramer post hoc comparison.
Clustering across variables was carried out only on those moments during which original observations for
all variables were present—this was limited to 5 min intervals (the storage rate for the mean HR and RMSSD),
mostly at night, due to the sleep-focused PPG activation used by the device manufacturer. Pearson’s correlations
were run on the simplified dataset of daily min and max values across all variables and all days.
We conducted wavelet analysis as previously reported22,30. Briefly, in-house code for wavelet decomposition
modified from the “Jlab” toolbox and from code developed by Dr. Tanya L
 eise31, using the morse wavelet (b = 5,
g = 3)32. Because wavelet transformations (WTs) exhibit artifacts at the edges of the data being transformed, we
excluded events identified in the WTs if they were within 2 periods from the edge of the data (e.g., 48 h at the
24 h period). To quantify 24 h power, the maximum for each timepoint (1-min resolution) was identified in the
band between 22–26 h periodicity, and the mean taken across 1440 min (24 h) windows. For comparison to the
onset of day-time fever-like events detected by our digital biomarker, peaks in wavelet power were defined as
the highest of surrounding daily maximums. Note that data pairs (peak:fever-like day) were omitted when peak
resulted from missing data or artifacts within data. To ensure data quality, all cases were reviewed by eye and
peaks resulting from missing or artifactual data were removed. Data reported are subsequent to this cleaning,
and so do not reflect artifactual peaks.

Data availability

Data used in this manuscript, and associated Matlab code, are available at the UCSD Research Data Library under
the following DOI information: Smarr, Benjamin L.; Aschbacher, Kirstin; Fisher, Sarah; Chowdhary, Anoushka;
Dilchert, Stephan; Puldon, Karena; Rao, Adam; Hecht, Frederick M.; Mason, Ashley E. yy. Data from: Feasibility
of continuous fever monitoring using wearable devices. UC San Diego Library Digital Collections. https://doi.
org/10.6075/J0ZW1JFX.
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